Stay updated on Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial
Sign up to get notified when there's something new on the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page.

Latest updates to the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page
- Check6 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a new version of the page. This change does not modify substantive content or functionality.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange Detected- Revision updated from v3.6.3 to v3.6.4, indicating a minor site update. The change does not alter study content or user-facing functionality.SummaryDifference0.1%

- Check27 days agoChange DetectedStudy timeline details were updated to show actual dates and enrollment, including a Primary Completion date of 2026-12-30 and a Study Completion date of 2027-12-30. Enrollment is now listed as 14, and the status labels indicate actual milestones rather than estimates.SummaryDifference0.6%

- Check42 days agoChange DetectedThe page now reflects a new Revision: v3.6.3, replacing the previous v3.6.2 revision. This is a metadata update indicating a released update to the page content without altering substantive information.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating a newer release of the page template or metadata. This update does not alter the visible content or study details.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page now shows recruitment status indicating no participants are being sought, and adds or updates help and navigation sections such as How to Read a Study Record, Common Questions, How to Join a Study, and an Intervention/Treatment header. The footer revision label changes from Revision: v3.5.5 to Revision: v3.6.0.SummaryDifference0.4%

Stay in the know with updates to Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page.